Search Results - "S. A. Tjuljandin"

Estrogen receptors, antiestrogens, and non-small cell lung cancer by Bogush, T. A, Dudko, E. A, Beme, A. A, Bogush, E. A, Kim, A. I, Polotsky, B. E, Tjuljandin, S. A, Davydov, M. I

“…This review considers data on expression of different types of estrogen receptors (ERα and ERβ) in in vitro cultured cells of non-small cell lung cancer and…”
Get full text

Discordance of Estrogen Receptor Status Between Primary and Metastatic Breast Cancer: Possible Reasons and Prognostic Value by T. A. Bogush, A. S. Popova, E. A. Dudko, E. O. Ignatova, B. E. Polotsky, S. A. Tjuljandin, M. I. Davydov

“…The aim of the review was systematization of the data on discordance in expression of estrogen receptors between primary and metastatic breast cancer,…”
Get full text

Estrogen Receptor Expression in Tumors Different from Breast Cancer by T. A. Bogush, E. A. Dudko, A. A. Beme, E. A. Bogush, B. E. Polotsky, S. A. Tjuljandin, M. I. Davydov

“…A review of the literature data on expression of estrogen receptor alpha and beta (ERa and ERβ) in tumors different from breast cancer. The results regarding…”
Get full text

New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy by T. A. Bogush, B. B. Polezhaev, E. A. Dudko, E. A. Bogush, V. Yu. Kirsanov, B. E. Polotsky, S. A. Tjuljandin, M. I. Davydov

“…Tamoxifen is the first target agent with a high-end position in breast cancer therapy till now. In recent years experimental researches revealed new biological…”
Get full text

Pharmacokinetics and toxicity of two schedules of high dose epirubicin by TJULJANDIN, S. A, DOIG, R. G, SOBOL, M. M, MCGREGOR WASTON, D, SHERIDAN, W. P, MORSTYN, G, MIHALY, G, GREEN, M. D

“…Epirubicin, a stereoisomer of doxorubicin, is reported to have equal antitumor activity with lower cardiac and systemic toxicity. Recently the maximum…”
Get full text

New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy by Bogush, T A, Polezhaev, B B, Dudko, E A, Bogush, E A, Kirsanov, V Yu, Polotsky, B E, Tjuljandin, S A, Davydov, M I

“…Tamoxifen is the first target agent with a high-end position in breast cancer therapy till now. In recent years experimental researches revealed new biological…”
Get more information

Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board by E V Artamonova, V A Gorbunova, N V Zhukov, L V Manzjuk, A G Manihas, P M Paltuev, V F Semiglazov, T Yu Semiglazova, M B Stenina, S A Tjuljandin, V A Chubenko

“…The leading oncologists' meeting was held on February 7, 2014 in Moscow. Those in attendance discussed treatment approaches ofbreast cancer, and in particular,…”
Get full text